Cargando…

Reduced Visual Field Activity Due to Covid-19 in a Patient With a Pituitary Macroadenoma

Background: Vision changes can be the presenting symptom of pituitary macroadenomas. The first-line therapy is transsphenoidal resection except for macroprolactinomas where medical therapy with dopamine agonist (DA) is the initial treatment of choice. Surgical resection is reserved if treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosner, Matthew Norman, Aridi, Ribal Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135458/
http://dx.doi.org/10.1210/jendso/bvab048.1237